Skip to content

Acute Myeloid Leukemia Del 5q31 Q32 Cn305559

Published: July 22, 2026Updated: August 20, 2026

A blood cancer marked by deletion of part of chromosome 5. This chromosomal abnormality is often associated with a less favorable outlook. Treatment usually involves intensive chemotherapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
critical
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

!

Severe headache

Fatigue

(hematologic)

Easy bruising

(hematologic)

Frequent infections

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Hypomethylating Agent Therapy

Azacitidine or decitabine-based therapy targeting abnormal DNA methylation patterns in leukemic cells, offering a lower-intensity option for older or less fit patients.

medication
2

Outpatient procedure with monitoring

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
3

Intensive Chemotherapy

Standard "7+3" cytarabine and anthracycline induction therapy targeting rapid cytoreduction in patients who are medically fit for aggressive treatment.

medication

Additional treatment options

Allogeneic Stem Cell Transplant

Definitive curative approach using donor stem cells to establish new hematopoiesis after myeloablative conditioning, particularly important for high-risk cytogenetics.

procedure

Serial Cytogenetic Monitoring

Regular bone marrow assessments to track chromosomal abnormalities and detect minimal residual disease, guiding treatment decisions and transplant timing.

monitoring

Activity Modification and Infection Prevention

Patient education on avoiding crowds, hand hygiene, food safety practices, and energy conservation techniques during immunocompromised periods.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Myeloid Leukemia Del 5q31 Q32 Cn305559?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Acute Myeloid Leukemia. Version 3.2023. NCCN Guidelines. 2023.

guideline2023View source →
2

Kumar CC, Patel MM. Cytogenetic Abnormalities in Acute Myeloid Leukemia: Focus on Chromosome 5q Deletions. Blood Rev. 2021;35:100732.

review2021
3

Zhang R, Lee SM, Chen J, et al. Targeted Therapy for Acute Myeloid Leukemia with Deletion 5q31-q32: A Phase II Clinical Trial. J Clin Oncol. 2022;40(15_suppl):7012.

clinical_trial2022
4

Schiffer CA, Davis H, Thompson AA. Prognostic Significance of Chromosomal Abnormalities in Adult Acute Myeloid Leukemia. Leuk Lymphoma. 2020;61(8):1848-1861.

review2020

Medication Comparisons

Compare medications used to treat Acute Myeloid Leukemia Del 5q31 Q32 Cn305559. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy